Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis: Results From TOPCAT.
Erwan DONAL : cardiologue CHU de Rennes Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis: Results From TOPCAT. https://pubmed.ncbi.nlm.nih.gov/34509404/ PMID : 34509404
The role of serial (99m)Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis
Pierre TROISFONTAINES – Cardiologue CHR de la Citadelle Liège – BELGIQUE The role of serial (99m)Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34704883/ PMID : 34704883
Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
Damien EYHARTS – cardiologue CHU de Toulouse Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis https://pubmed.ncbi.nlm.nih.gov/34643339/ PMID : 34643339
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.
Thibaut WAJCHERT – Dr Junior au CHU de Versailles Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/32981389/ PMID : 32981389
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic
François ROUBILLE – cardiologue resp. équipe médicale insuffisance cardiaque – CHU Montpellier Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic https://pubmed.ncbi.nlm.nih.gov/33352187/ PMID : 33352187
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.
Anne-Catherine POULEUR – chef de clinique service de cardiologie – institut cardiovasculaire Saint Luc – BRUXELLES BELGIQUE Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. – https://pubmed.ncbi.nlm.nih.gov/32653448/ PMID : 32653448
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
Frédéric MOUQUET – cardiologue LIlle Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34497140/ PMID : 34497140
Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis.
Lise LEGRAND – Cardiologue APHP Pitié Salpêtrière PARIS Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis. JACC CardioOncol2020;2:414–42 – https://pubmed.ncbi.nlm.nih.gov/33073249/ PMID : 33073249
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis.
Damien GUIJARRO Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34419399/ PMID : 34419399
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Patricia REANT Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. https://pubmed.ncbi.nlm.nih.gov/34472567/ PMID : 34472567